SCHEMBL6173145

SCHEMBL6173145

CC(c1ccnc2ccc(N)cc12)C1(C(C)c2ccnc3ccc(N)cc23)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.43
AR P10275 3/20 0.35
HRH4 Q9H3N8 4/20 0.33
KMT2A Q03164 2/20 0.33
CNR1 P21554 2/20 0.33
TP53 P04637 2/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
PGR P06401 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31
ALOX12 P18054 1/20 0.31
NFKB1 P19838 1/20 0.31
CYP2C19 P33261 1/20 0.31
RAB9A P51151 1/20 0.31
PDE4D Q08499 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171792 0.90 IGF1R (0.44) IGF1RARKMT2ACNR1TP53
SCHEMBL6174619 0.90 IGF1R (0.43) IGF1RARKMT2ACNR1TP53
SCHEMBL6172835 0.88 IGF1R (0.42) IGF1RARKMT2ACNR1TP53
SCHEMBL6174623 0.88 IGF1R (0.42) IGF1RARHRH4KMT2ACNR1
SCHEMBL6174593 0.88 IGF1R (0.42) IGF1RARKMT2AMEN1LMNA
SCHEMBL6174964 0.85 TRPV1 (0.35) ARKMT2AMEN1CYP3A4CYP2C9
SCHEMBL6176113 0.85 IGF1R (0.42) IGF1RARHRH4KMT2ATP53
SCHEMBL6172572 0.83 IGF1R (0.41) IGF1RARHRH4KMT2ATP53
SCHEMBL6173546 0.80 KMT2A (0.36) IGF1RARKMT2ATP53LMNA
SCHEMBL6173625 0.80 IGF1R (0.44) IGF1RARKMT2ATP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed